Stratec Biomedical AG | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
15,478.00
19,768.00
22,084.00
19,497.00
25,635.00
8,969
Depreciation, Depletion & Amortization
2,562.00
7,971.00
4,682.00
11,208.00
18,981.00
21,646
Other Funds
3,575.00
1,249.00
1,679.00
623.00
522.00
2,368
Funds from Operations
22,677.00
32,844.00
26,217.00
28,140.00
40,002.00
31,701
Changes in Working Capital
1,160.00
6,908.00
184.00
11,884.00
10,021.00
19,751
Net Operating Cash Flow
23,837.00
39,752.00
26,033.00
16,256.00
29,981.00
11,950
Capital Expenditures
10,093.00
6,689.00
8,864.00
9,979.00
15,666.00
Sale of Fixed Assets & Businesses
27.00
176.00
157.00
82.00
22.00
Purchase/Sale of Investments
100.00
82.00
-
54.00
4.00
Net Investing Cash Flow
10,208.00
6,818.00
8,710.00
86,728.00
15,640.00
Cash Dividends Paid - Total
6,566.00
7,055.00
8,248.00
8,885.00
9,129.00
Issuance/Reduction of Debt, Net
68.00
1,649.00
2,087.00
49,237.00
8,659.00
Net Financing Cash Flow
5,831.00
8,012.00
8,661.00
40,606.00
15,978.00
Net Change in Cash
7,525.00
25,902.00
9,701.00
29,966.00
2,363.00
Free Cash Flow
21,262.00
38,278.00
20,595.00
9,050.00
20,669.00
Deferred Taxes & Investment Tax Credit
1,062.00
3,856.00
1,130.00
3,188.00
4,092.00
1,282
Net Assets from Acquisitions
126.00
-
3.00
76,885.00
-
Other Sources
84.00
-
-
-
-
Change in Capital Stock
803.00
692.00
1,674.00
254.00
1,810.00
Exchange Rate Effect
273.00
980.00
1,039.00
100.00
726.00
Other Uses
-
223.00
-
-
-
About Stratec Biomedical
View Profile
